Goldman Sachs Starts Medivation (MDVN) at Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Goldman Sachs Starts Medivation (MDVN) at Neutral

Xtandi Congressional Letter and CFO Change a Modest Negative at Worst for Medivation (MDVN) - UBS

March 29, 2016 8:38 AM EDT

UBS Analyst, Matthew Roden, sees the Medivation (NASDAQ: MDVN) CFO change as a positive and the Congressional letter threatening Xtandi pricing as a modest negative at worst. No change to Buy rating or $50 PT.

In the short term, the transition may lessen the recent acquisition premium that followed media M&A speculation, but adding a deal-oriented CFO to the management team could... More

After-Hours Stock Movers 03/28: (FL) (DCT) (ALDR) Higher; (ALXA) (GEVO) (PBYI) Lower (more...)

March 28, 2016 6:11 PM EDT

Alexza Pharmaceuticals Inc. (NASDAQ: ALXA) 49.7% LOWER; warns it may shut-down if it is unable to source additional capital.

Gevo, Inc. (Nasdaq: GEVO) 21.7% LOWER; announced that it intends to offer and sell, subject to market and other conditions, Series C units, with each Series C unit consisting of one share of common stock, Series F warrants to purchase a certain number of shares of common stock and Series H warrants to purchase a certain number of... More

Members of Congress Ask NIH and HHS to Examine Xtandi Pricing (MDVN) - CNBC

March 28, 2016 4:41 PM EDT

Eleven members of Congress asked NIH and HHS to examine Xtandi pricing, according to CNBC, citing a letter. The headline sent shares of Medivation (Nasdaq: MDVN) sharply lower after-hours.

12 congressmen ask NIH, HHS to examine $MDVN's Xtandi pricing. Letter here: https://t.co/kaodTemjvc

Meg Tirrell (@megtirrell) March 28, 2016

... More